Medidata Unveils Transformative Solutions and Collaborations at NEXT New York, Driving Paradigm Shift in Life Sciences and Healthcare
13 Novembro 2024 - 10:00AM
Business Wire
Medidata, a Dassault Systèmes brand and leader of clinical trial
solutions to the life sciences industry, is kicking off NEXT New
York 2024, its premier life sciences conference. Uniting more than
1,000 healthcare customers and partners, the event will showcase
AI-powered innovations that accelerate clinical trials, streamline
data management, and enhance decision-making for life-saving
therapies.
At the event, Medidata will unveil three experiences centered on
the full ecosystem of clinical trials—data management, patient
engagement, and study coordination—providing tools that streamline
trial workflows and enhance patient lives. Powered by the world’s
largest collection of anonymized and de-identified historical
clinical trial data, AI continues to be a foundational element in
everything Medidata offers, allowing these experiences to be
infused with machine learning and other technologies, such as
Medidata Designer and Medidata Rave Lite.
“NEXT New York is our most important event of the year, and
we're excited to share new insights and fresh approaches,” said
Anthony Costello, CEO, Medidata. “Across two days, we’ll immerse
our customers in clinical development, offering insights into our
shift from individual products to integrated, patient-centered
experiences. We’ll also highlight strategies that simplify trial
operations, enhance patient engagement, and prioritize effective
data capture and integration from ever more complex sources.”
The conference will feature over 35 customer and partner
speeches, from Cogstate, Click Therapeutics, CNS Healthcare,
Snowflake, and more, exploring such diverse topics such as AI’s
profound impact on clinical research, the extension of longitudinal
relationships with patients, and more.
Conference participants will also engage in 28 breakout sessions
covering topics that include AI-enabled trial design, central
nervous system trials, and more. Additionally, they can join in on
three immersive experiences, including the lifecycle of a site from
the sponsor's perspective, a data point journey from acquisition to
application, and a day-in-the-life of a clinical trial patient.
These hands-on demos will provide exclusive insights into
Medidata's cutting-edge solutions and site relationships.
To learn more about Medidata NEXT New York, click here, and to
register for virtual keynote sessions, click here.
About Medidata
Medidata is powering smarter treatments and healthier people
through digital solutions to support clinical trials. Celebrating
25 years of ground-breaking technological innovation across more
than 34,000 trials and 10 million patients, Medidata offers
industry-leading expertise, analytics-powered insights, and the
largest patient-level historical clinical trial data set in the
world. More than 1 million registered users across approximately
2,200 customers trust Medidata’s seamless, end-to-end platform to
improve patient experiences, accelerate clinical breakthroughs, and
bring therapies to market faster. A Dassault Systèmes brand
(Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered
in New York City and has been recognized as a Leader by Everest
Group and IDC. Discover more at www.medidata.com and follow us
@Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. We provide
business and people with collaborative virtual environments to
imagine sustainable innovations. By creating virtual twin
experiences of the real world with our 3DEXPERIENCE platform and
applications, our customers can redefine the creation, production
and life-cycle-management processes of their offer and thus have a
meaningful impact to make the world more sustainable. The beauty of
the Experience Economy is that it is a human-centered economy for
the benefit of all – consumers, patients and citizens. Dassault
Systèmes brings value to more than 350,000 customers of all sizes,
in all industries, in more than 150 countries. For more
information, visit www.3ds.com.
© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS
logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA,
CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE,
SIMULIA and SOLIDWORKS are commercial trademarks or registered
trademarks of Dassault Systèmes, a European company (Societas
Europaea) incorporated under French law, and registered with the
Versailles trade and companies registry under number 322 306 440,
or its subsidiaries in the United States and/or other countries.
All other trademarks are owned by their respective owners. Use of
any Dassault Systèmes or its subsidiaries trademarks is subject to
their express written approval.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241113854965/en/
Medidata PR Medidata.PR@3ds.com
Analyst Relations medidata.AR@3ds.com
Big Tree Cloud (NASDAQ:DSY)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Big Tree Cloud (NASDAQ:DSY)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024